Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Aug 11, 2026

Teleflex Inc (TFX)

A forensic read on Teleflex Inc built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution

Forensic grade

Safe

Financial health

4.3

Distress distance

Clean

Earnings quality

Forensic signals

-5.8

P / E (ttm)

-29.0%

ROE

$5.7B

Market cap

0.98%

Dividend yield

17.2%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Teleflex Inc earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 4.3, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

1.8%

FY2025

Return on invested capital. Return on invested capital is 1.8% in the latest fiscal year and slipping from 7% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.

24915% of FCF

FY2025

Shareholder returns. Returned $360M to shareholders (buybacks + dividends) in FY2025 — 24915% of free cash flow. More than free cash flow generated — and beyond operating cash too, so the extra is coming from debt or cash reserves, which isn't sustainable indefinitely. Counting the $26M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 26692%.

$240M

FY2024–FY2024

Goodwill impairments. Took $240M of goodwill writedowns across 1 year (FY2024 ($240M)) — about 344% of net income over the span. A large writedown means an acquisition turned out worth far less than was paid — a real mark against M&A discipline.

Key fundamentals

Latest Revenue$1.99B

Revenue Growth YoY+17.2%

Revenue CAGR (3yr)-10.6%

Net Margin-45.4%

Free Cash Flow$1.4M

Return on Equity-29.0%

Debt / Equity0.85x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Teleflex Inc's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 11, 2026. Forensic signals flag probability, not certainty.